Sunshine Biopharma Stock Forward View
| SBFMW Stock | USD 0.17 0.07 29.17% |
Sunshine Stock outlook is based on your current time horizon.
The RSI of Sunshine Biopharma's stock price is slightly above 63. This usually implies that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Sunshine, making its price go up or down. Momentum 63
Buy Extended
Oversold | Overbought |
Quarterly Revenue Growth 0.116 |
Using Sunshine Biopharma hype-based prediction, you can estimate the value of Sunshine Biopharma Warrant from the perspective of Sunshine Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Sunshine Biopharma Warrant on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.78. Sunshine Biopharma after-hype prediction price | USD 0.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sunshine Biopharma to cross-verify your projections. Sunshine Biopharma Additional Predictive Modules
Most predictive techniques to examine Sunshine price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sunshine using various technical indicators. When you analyze Sunshine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Sunshine Biopharma's financial statements to predict how it will affect future prices.
Cash | First Reported 2007-09-30 | Previous Quarter 10.3 M | Current Value 9.3 M | Quarterly Volatility 9 M |
Sunshine Biopharma Naive Prediction Price Forecast For the 2nd of March
Given 90 days horizon, the Naive Prediction forecasted value of Sunshine Biopharma Warrant on the next trading day is expected to be 0.19 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.78.Please note that although there have been many attempts to predict Sunshine Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sunshine Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sunshine Biopharma Stock Forecast Pattern
| Backtest Sunshine Biopharma | Sunshine Biopharma Price Prediction | Research Analysis |
Sunshine Biopharma Forecasted Value
In the context of forecasting Sunshine Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sunshine Biopharma's downside and upside margins for the forecasting period are 0 and 20.77, respectively. We have considered Sunshine Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sunshine Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Sunshine Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.4778 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0292 |
| MAPE | Mean absolute percentage error | 0.1501 |
| SAE | Sum of the absolute errors | 1.78 |
Predictive Modules for Sunshine Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sunshine Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sunshine Biopharma After-Hype Price Density Analysis
As far as predicting the price of Sunshine Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sunshine Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sunshine Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sunshine Biopharma Estimiated After-Hype Price Volatility
In the context of predicting Sunshine Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sunshine Biopharma's historical news coverage. Sunshine Biopharma's after-hype downside and upside margins for the prediction period are 0.01 and 20.77, respectively. We have considered Sunshine Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sunshine Biopharma is out of control at this time. Analysis and calculation of next after-hype price of Sunshine Biopharma is based on 3 months time horizon.
Sunshine Biopharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sunshine Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sunshine Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sunshine Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.87 | 20.58 | 0.02 | 0.01 | 5 Events / Month | 2 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.17 | 0.19 | 11.76 |
|
Sunshine Biopharma Hype Timeline
Sunshine Biopharma is at this time traded for 0.17. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.01. Sunshine is expected to increase in value after the next headline, with the price projected to jump to 0.19 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 11.76%, whereas the daily expected return is at this time at 0.87%. The volatility of related hype on Sunshine Biopharma is about 257250.0%, with the expected price after the next announcement by competition of 0.18. Sunshine Biopharma Warrant has accumulated 952.48 K in total debt with debt to equity ratio (D/E) of 8.98, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sunshine Biopharma has a current ratio of 83.39, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Note, when we think about Sunshine Biopharma's use of debt, we should always consider it together with its cash and equity.Assuming the 90 days horizon the next expected press release will be in about 5 days. Check out Historical Fundamental Analysis of Sunshine Biopharma to cross-verify your projections.Sunshine Biopharma Related Hype Analysis
Having access to credible news sources related to Sunshine Biopharma's direct competition is more important than ever and may enhance your ability to predict Sunshine Biopharma's future price movements. Getting to know how Sunshine Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sunshine Biopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APRE | Aprea Therapeutics | 0.23 | 14 per month | 0.00 | (0.03) | 11.29 | (10.58) | 46.26 | |
| ADIL | Adial Pharmaceuticals | 0.02 | 5 per month | 0.00 | (0.33) | 5.70 | (8.24) | 34.48 | |
| KPRX | Kiora Pharmaceuticals | 0.04 | 4 per month | 2.52 | 0.04 | 4.44 | (3.90) | 16.69 | |
| CDIO | Cardio Diagnostics Holdings | (0.23) | 7 per month | 6.07 | 0.15 | 25.48 | (13.93) | 80.69 | |
| PHIO | Phio Pharmaceuticals Corp | (0.02) | 9 per month | 5.60 | 0.03 | 7.34 | (9.65) | 56.33 |
Other Forecasting Options for Sunshine Biopharma
For every potential investor in Sunshine, whether a beginner or expert, Sunshine Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sunshine Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sunshine. Basic forecasting techniques help filter out the noise by identifying Sunshine Biopharma's price trends.Sunshine Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sunshine Biopharma stock to make a market-neutral strategy. Peer analysis of Sunshine Biopharma could also be used in its relative valuation, which is a method of valuing Sunshine Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sunshine Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Sunshine Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sunshine Biopharma shares will generate the highest return on investment. By undertsting and applying Sunshine Biopharma stock market strength indicators, traders can identify Sunshine Biopharma Warrant entry and exit signals to maximize returns.
Sunshine Biopharma Risk Indicators
The analysis of Sunshine Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sunshine Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sunshine stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 13.23 | |||
| Semi Deviation | 12.34 | |||
| Standard Deviation | 19.3 | |||
| Variance | 372.42 | |||
| Downside Variance | 251.04 | |||
| Semi Variance | 152.3 | |||
| Expected Short fall | (22.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sunshine Biopharma
The number of cover stories for Sunshine Biopharma depends on current market conditions and Sunshine Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sunshine Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sunshine Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sunshine Biopharma Short Properties
Sunshine Biopharma's future price predictability will typically decrease when Sunshine Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sunshine Biopharma Warrant often depends not only on the future outlook of the potential Sunshine Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sunshine Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 701.7 K | |
| Cash And Short Term Investments | 9.7 M |
Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.